is a Biotechnology Research company. Talus Bioscience is a company that combines functional proteomics, automated biology, and machine learning to target hard-to-treat transcription factor proteins driving cancer and beyond. Talus Bio employs 24 people (+13.0% YoY, +3 people) and has an annual revenue of $2.0M, founded in 2020. Headquartered in Seattle, Washington, United States. Has $39.7M in total funding, most recently a Seed Round in August ... Talus Bio is making the regulome visible a